Sort
82,697 grants matching “vaccine development”
Development of an effective therapy against post-exposure Anthrax
$1,138,413Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2007 · AI
Critical Path Project: Mapp66, a Multi-antibody Prevention Product
$1,138,391Kevin John Whaley · Boston University Medical Campus · U19 · FY2013 · AI
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$1,137,992Rong Fan · Yale University · U01 · FY2023 · CA
Personalized Cystic Fibrosis Therapy and Research Center
$1,137,847Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2022 · DK
Pediatric AIDS Clinical Trials Group
$1,137,764St. Jude Children'S Research Hospital · U01 · FY2002 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,137,646Jeffrey A Roberts · University Of California At Davis · U42 · FY2015 · OD
Vaccine and Treatment Evaluation Units
$1,137,245Nadine Georges Rouphael · Emory University · UM1 · FY2024 · AI
Heterodimeric IL-15 in Cancer Immunotherapy
$1,137,140George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVVDT)
$1,136,715Jeffrey D Chulay · · N01 · FY2007 · AI
HIV Vaccine Design and Development Teams (HVDDT)
$1,136,715 · N01 · FY2007 · AI
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,136,693Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Crossprotective CTL Against Influenza
$1,136,663Ellis L Reinherz · Dana-Farber Cancer Inst · U01 · FY2014 · AI
Crossprotective CTL Against Influenza
$1,136,663Ellis L Reinherz · Dana-Farber Cancer Inst · U01 · FY2012 · AI
Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity
$1,136,661Lallan Giri · Biologics Resources, Llc · R01 · FY2013 · AI
NIAID Preclinical Development Support - Development of clade C Vaccine
$1,136,533Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
Immunobiology of Influenza Virus-related Critical Illness in Young Hosts
$1,136,468Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2022 · AI
Structure-Based Vaccine Design for Hepatits C Virus
$1,136,335Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2019 · AI
Administrative Core
$1,136,092David Mitchell Smith · University Of California, San Diego · P30 · FY2020 · AI
Center of Excellence on Race, Ethnicity and Health Disparities Research
$1,136,019Stephen B. Thomas · Univ Of Maryland, College Park · P20 · FY2013 · MD
Molecular Genetics Of Scrapie Pathogenesis
$1,135,879Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,135,847Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2007 · CA
New Strategies to Prevent Death from Influenza
$1,135,759Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2007 · AI
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,135,695Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Core-001
$1,135,654Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Experimental Therapeutics of Pediatric Hematopoietic Malignancies
$1,135,420Alan S Wayne · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA